Genetic Technologies announces a partnership with the Gold Coast Private Hospital, GCPH, a member of Healthscope, to establish a Precision Medicine Clinic at the hospital. Highlights: Partnership will be initiated with a 50-patient pilot study to establish workflow and patient reporting. Pilot study will utilise geneType Multi-risk test combined with Pharmacogenomics tests, providing a comprehensive wellness profile for GCPH patients. Patient recruitment to commence immediately. Positive outcomes could enable the rollout of additional Precision Medicine Clinics throughout the Healthscope network. Gold Coast Private Hospital by Healthscope is a 336 bed, 22 theatre hospital and home to leading doctors and surgeons from around the world.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GENE:
- GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
- GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research – MRFF Grant names GTG as sole Industry Partner
- Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
- Genetic Technologies reports 2023 revenue A$8.69M, up 28% vs. 2022
- Annual Results – Momentum Building on our Commercial Plans
